Nanomedicine News

RSS

Nanoparticles Specifically Target Tough Cancer Stem Cells

Many cancer patients survive treatment only to have a recurrence within a few years. Recurrences and tumor spreading are likely due to cancer stem cells that can be tough to kill with conventional cancer drugs.

11 Jun 2015

Immune Pharmaceuticals Successfully Incorporates Cyclosporine A into Biodegradable Nano-Capsules

Immune Pharmaceuticals Inc. announced today that it has entered into a binding Memorandum of Understanding with Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem regarding the worldwide exclusive licensing and development of a topical, biodegradable, nano-capsule formulation of cyclosporine A.

11 Jun 2015

Positive Intermediate Results from Nanobiotix’s NBTXR3 Phase I/II Clinical Trial in Head and Neck Cancer

NANOBIOTIX (Paris:NANO) (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces positive preliminary safety results for its lead NanoXray product NBTXR3, in its head and neck cancer Phase I/II clinical trial.

10 Jun 2015

Nanoparticles Arrest Destruction of Beta Cells and Avoid Diabetes Development

Two years ago, the Immunology of Diabetes Research Group at the Germans Trias Research Institute (at Universitat Autònoma de Barcelona - Campus of International Excellence Sphere) reported a new experimental immunotherapy that prevented the onset of Type 1 Diabetes in mice predisposed to the disease.

10 Jun 2015

Injectable Nano-Scale Electronic Scaffolds to Monitor Neural Activity

It's a notion that might be pulled from the pages of science-fiction novel - electronic devices that can be injected directly into the brain, or other body parts, and treat everything from neurodegenerative disorders to paralysis.

9 Jun 2015

Innovative Hand-Held Tool and App to Monitor for Signs of Skin Cancer Unveiled at World Dermatology Conference

Simon Fraser University PhD alumna Maryam Sadeghi is unveiling MoleScope™, an innovative hand-held tool that uses a smartphone to monitor skin for signs of cancer, at the World Congress of Dermatology conference in Vancouver June 9-13.

9 Jun 2015

NCI Nanotechnology Characterization Laboratory Selects Rexahn’s RX-21101 for Preclinical Characterization Program

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that its drug candidate RX-21101 was selected by the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL) for its preclinical characterization program to help facilitate the advance of RX-21101 towards human clinical trials.

9 Jun 2015

Nanotechniques Developed in Space Could Help Better Understand Deep Brain Stimulation

Applying nanotechniques developed in the U.S. space program may help to better understand the electrochemical dynamics of deep brain stimulation in order to fine-tune the therapy, according to a presentation by NASA Ames Research Center scientist Russell J. Andrews, M.D., at the International Neuromodulation Society’s 12th World Congress.

9 Jun 2015

Graphene-Coated Catheters May Improve Delivery of Chemotherapy Drugs

A new study published in IOP Publishing's journal 2D Materials has proposed using graphene as an alternative coating for catheters to improve the delivery of chemotherapy drugs.

3 Jun 2015

Global Antiviral Therapeutics Report Features Potential for Nanotechnology in Virology

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Antiviral Therapeutics - Technologies, Markets and Companies" to their offering.

2 Jun 2015

Nanomedicine News

Nanoparticles Specifically Target Tough Cancer Stem Cells

Immune Pharmaceuticals Successfully Incorporates Cyclosporine A into Biodegradable Nano-Capsules

Positive Intermediate Results from Nanobiotix’s NBTXR3 Phase I/II Clinical Trial in Head and Neck Cancer

Nanoparticles Arrest Destruction of Beta Cells and Avoid Diabetes Development

Injectable Nano-Scale Electronic Scaffolds to Monitor Neural Activity

Innovative Hand-Held Tool and App to Monitor for Signs of Skin Cancer Unveiled at World Dermatology Conference

NCI Nanotechnology Characterization Laboratory Selects Rexahn’s RX-21101 for Preclinical Characterization Program

Nanotechniques Developed in Space Could Help Better Understand Deep Brain Stimulation

Graphene-Coated Catheters May Improve Delivery of Chemotherapy Drugs

Global Antiviral Therapeutics Report Features Potential for Nanotechnology in Virology

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials